Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Poland
- United Kingdom
- Portugal
- Denmark
- Sweden
- Canada
- Spain
- Norway
- Romania
- France
- India
- Germany
- China
- Singapore
- Croatia
- Hong Kong
- Netherlands
- United Arab Emirates
- Australia
- Switzerland
- Finland
- Austria
- Czech
- Belgium
- Brazil
- Cyprus
- Italy
- Japan
- Latvia
- Mexico
- Slovakia
- Slovenia
- South Africa
- 24 more »
- « less
-
Program
-
Field
-
, kinesiology, human movement science, or a closely related field, with prior research experience involving human participants and a record of first-author peer-reviewed publication. Preferred Clinical licensure
-
. About GSK GSK is a focused biopharma company with strong momentum and big ambitions, to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
carried out are: • Explorer in the CAGEP-MS study, recruiting participants, coordinating visits and as an evaluator, proofreader, writer and return of reports. Approximately from April 11, 2027 and until
-
global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis
-
are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered
-
are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered
-
. About Vertex Pharmaceuticals Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company
-
. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved